Koers Bristol-Myers Squibb Company Swiss Exchange
Aandelen
BMY
US1101221083
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Nabeurs 21:52:42 | |||
45,3 USD | -0,90% | 44,64 | -1,45% |
Omzet 2024 * | 46,02 mld. 42,3 mld. | Omzet 2025 * | 46,15 mld. 42,42 mld. | Marktkapitalisatie | 90,63 mld. 83,3 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -5,41 mld. -4,98 mld. | Nettowinst (verlies) 2025 * | 10,22 mld. 9,39 mld. | EV/omzet 2024 * | 2,82 x |
Nettoschuld 2024 * | 39,2 mld. 36,03 mld. | Nettoschuld 2025 * | 31,85 mld. 29,28 mld. | EV/omzet 2025 * | 2,65 x |
K/w-verhouding 2024 * |
-17
x | K/w-verhouding 2025 * |
8,45
x | Werknemers | - |
Dividendrendement 2024 * |
5,38% | Dividendrendement 2025 * |
5,65% | Vrij verhandelbaar | 69,27% |
Recentste transcriptie over Bristol-Myers Squibb Company
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 01-02-15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01-04-16 |
Derica Rice
BRD | Director/Board Member | 59 | 01-09-20 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,76% | 364 mld. | |
+20,58% | 326 mld. | |
+5,58% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+11,11% | 167 mld. | |
+0,10% | 161 mld. |